FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074313096> ?p ?o ?g. }

• W2074313096 endingPage "476" @default.
• W2074313096 startingPage "469" @default.
• W2074313096 abstract "The purpose of this study was to compare the impact of drug therapy on weight loss, Beck Depression Inventory (BDI) scores, and binge eating patterns (BES) between obese binge eaters and non-binge eaters.22 severe binge eaters, 17 moderate binge eaters, and 16 non-binge eaters received phentermine resin 15mg/day and dl-fenfluramine 20mg three times daily over a 6 month period for weight loss. All data are reported as mean+/-S.The percent weight loss compared to baseline within the 3 groups ranged from 8.9% to 11.3% at 3 months and 10.6% to 14.9% at 6 months. After 6 months, 73% of the severe binge eaters, 59% of moderate binge eaters and 69% of non-binge eaters had experienced more than 10% weight loss. BDI scores were significantly higher in the severe group at baseline when compared to non-binge eaters (p<0.006). After 3 and 6 months BDI scores improved in all groups but remained significantly different between the severe and non-binge eaters until the 6-month assessment. BES scores declined in all groups over the 6-month period. Echocardiograms were performed in 35 of 55 subjects following reports of a possible association between fenfluramine and valvular changes. Fifteen (43%) of subjects had no abnormal findings and 20 (57%) had evidence of valvular insufficiency occurring in one or more valves. Seven patients (20%) had significant valve damage according to the DHHS and FDA criteria.After 24 weeks of treatment severe binge eaters improved their eating pattern, depression scores, and achieved weight loss similar to non-binge eaters. These data suggest that pharmacologic intervention for weight loss and subsequent weight maintenance can be as successful in binge eaters as non-binge eaters. A relationship was seen between duration of drug treatment and valvular insufficiency in subjects treated for an average of 52 weeks. These findings validate the FDA requirement for studies of at least 1 year duration to evaluate both the safety and efficacy of pharmacologic treatment for obesity." @default.
• W2074313096 created "2016-06-24" @default.
• W2074313096 creator A5003167091 @default.
• W2074313096 creator A5026510177 @default.
• W2074313096 creator A5029397447 @default.
• W2074313096 creator A5058651481 @default.
• W2074313096 creator A5065288120 @default.
• W2074313096 date "1999-09-01" @default.
• W2074313096 modified "2023-09-26" @default.
• W2074313096 title "Beneficial Effects of Pharmacotherapy on Weight Loss, Depressive Symptoms, and Eating Patterns in Obese Binge Eaters and Non-Binge Eaters" @default.
• W2074313096 cites W1684647427 @default.
• W2074313096 cites W1699599263 @default.
• W2074313096 cites W1941934316 @default.
• W2074313096 cites W1964492099 @default.
• W2074313096 cites W1983474740 @default.
• W2074313096 cites W1984521643 @default.
• W2074313096 cites W2021332243 @default.
• W2074313096 cites W2024517711 @default.
• W2074313096 cites W2027040058 @default.
• W2074313096 cites W2043734328 @default.
• W2074313096 cites W2046295715 @default.
• W2074313096 cites W2053054105 @default.
• W2074313096 cites W2060565961 @default.
• W2074313096 cites W2063358799 @default.
• W2074313096 cites W2067495470 @default.
• W2074313096 cites W2069695428 @default.
• W2074313096 cites W2085140725 @default.
• W2074313096 cites W2086564524 @default.
• W2074313096 cites W2092628994 @default.
• W2074313096 cites W2096743139 @default.
• W2074313096 cites W2122944518 @default.
• W2074313096 cites W2132930967 @default.
• W2074313096 cites W2134362869 @default.
• W2074313096 cites W2140788461 @default.
• W2074313096 cites W2161001082 @default.
• W2074313096 cites W2317237918 @default.
• W2074313096 cites W2337606293 @default.
• W2074313096 cites W2408913104 @default.
• W2074313096 cites W3187158842 @default.
• W2074313096 cites W4234750564 @default.
• W2074313096 cites W4234944065 @default.
• W2074313096 cites W4302901413 @default.
• W2074313096 doi "https://doi.org/10.1002/j.1550-8528.1999.tb00435.x" @default.
• W2074313096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10509604" @default.
• W2074313096 hasPublicationYear "1999" @default.
• W2074313096 type Work @default.
• W2074313096 sameAs 2074313096 @default.
• W2074313096 citedByCount "30" @default.
• W2074313096 countsByYear W20743130962012 @default.
• W2074313096 countsByYear W20743130962013 @default.
• W2074313096 countsByYear W20743130962020 @default.
• W2074313096 countsByYear W20743130962021 @default.
• W2074313096 countsByYear W20743130962022 @default.
• W2074313096 crossrefType "journal-article" @default.
• W2074313096 hasAuthorship W2074313096A5003167091 @default.
• W2074313096 hasAuthorship W2074313096A5026510177 @default.
• W2074313096 hasAuthorship W2074313096A5029397447 @default.
• W2074313096 hasAuthorship W2074313096A5058651481 @default.
• W2074313096 hasAuthorship W2074313096A5065288120 @default.
• W2074313096 hasConcept C118552586 @default.
• W2074313096 hasConcept C126322002 @default.
• W2074313096 hasConcept C139719470 @default.
• W2074313096 hasConcept C15744967 @default.
• W2074313096 hasConcept C162324750 @default.
• W2074313096 hasConcept C170493617 @default.
• W2074313096 hasConcept C190385971 @default.
• W2074313096 hasConcept C2775864247 @default.
• W2074313096 hasConcept C2776394216 @default.
• W2074313096 hasConcept C2776679223 @default.
• W2074313096 hasConcept C2776867660 @default.
• W2074313096 hasConcept C2777556793 @default.
• W2074313096 hasConcept C2778202721 @default.
• W2074313096 hasConcept C2778456266 @default.
• W2074313096 hasConcept C2779631380 @default.
• W2074313096 hasConcept C2779638493 @default.
• W2074313096 hasConcept C2781426410 @default.
• W2074313096 hasConcept C3017944768 @default.
• W2074313096 hasConcept C511355011 @default.
• W2074313096 hasConcept C544821477 @default.
• W2074313096 hasConcept C558461103 @default.
• W2074313096 hasConcept C71924100 @default.
• W2074313096 hasConcept C99454951 @default.
• W2074313096 hasConceptScore W2074313096C118552586 @default.
• W2074313096 hasConceptScore W2074313096C126322002 @default.
• W2074313096 hasConceptScore W2074313096C139719470 @default.
• W2074313096 hasConceptScore W2074313096C15744967 @default.
• W2074313096 hasConceptScore W2074313096C162324750 @default.
• W2074313096 hasConceptScore W2074313096C170493617 @default.
• W2074313096 hasConceptScore W2074313096C190385971 @default.
• W2074313096 hasConceptScore W2074313096C2775864247 @default.
• W2074313096 hasConceptScore W2074313096C2776394216 @default.
• W2074313096 hasConceptScore W2074313096C2776679223 @default.
• W2074313096 hasConceptScore W2074313096C2776867660 @default.
• W2074313096 hasConceptScore W2074313096C2777556793 @default.
• W2074313096 hasConceptScore W2074313096C2778202721 @default.
• W2074313096 hasConceptScore W2074313096C2778456266 @default.
• W2074313096 hasConceptScore W2074313096C2779631380 @default.
• W2074313096 hasConceptScore W2074313096C2779638493 @default.

• next